Today, on March 14th, the joint ICMS-IBEC symposium took place. This event was co-organized by IBEC and the Institute for Complex Molecular Systems (ICMS). Throughout the conference, researchers from both IBEC and ICMS presented their areas of research, aiming to enhance the scientific collaboration between the two institutions.
Dear all, It is our pleasure to invite you to the ICMS-IBEC symposium on 14 March from 13.00 – 17.00 (Ceres 0.31, coffee starts at 12.45). Colleagues from both … Read more
Ref: LT_SS // Deadline: 20/03/2024
Today, the event “Advances in Ataxia Telangiectasia” took place, organized by the Institute of Bioengineering of Catalonia (IBEC) in collaboration with AEFAT, the Spanish ataxia-telangiectasia family association. The gathering brought together patients’ families, researchers, and clinicians to explore the latest advancements in the clinical management of ataxia telangiectasia.
The project focuses on developing a chip that will serve as a model for testing new drugs to treat neuroblastoma, a childhood brain cancer. The research has received €200,000 in funding and is led by Aránzazu Villasante, Senior Researcher at IBEC.
Cell-Derived Extracellular Matrices for 3D in vitro Tumor Models Gülsun Bagci, Biomaterials for Regenerative Therapies Group Decellularized Extracellular matrices are new scaffolds for bioengineering of 3D tumor-ECM in vitro models. … Read more
At IBEC we combine expertise in various data sources with advanced techniques and data analysis to unlock valuable insights for disease diagnosis, monitoring, and treatment.
IBEC is at the forefront of sensor design, fabrication, and integration for a wide range of applications. IBEC possesses expertise in developing both biological and chemical sensors, encompassing all aspects … Read more
IBEC is a leader in developing innovative biological models to study human diseases and treatment responses. These models provide a powerful toolset for researchers and industry, offering: